Avacta Group PLC

NEW
OTCPK:AVCTF (UK)  
$ 1 (0%) 11:08 PM EST
At Loss
P/B:
121.67
Market Cap:
$ 448.38M
Enterprise V:
$ 445.44M
Volume:
0
Avg Vol (2M):
78.80K
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
78.80K

Business Description

Description
Avacta Group PLC is a clinical-stage life sciences company expanding the reach of potent cancer therapies with the pre-CISION platform. pre-CISION is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation protein or FAP) that is designed to concentrate potent warheads in the tumor microenvironment while sparing normal tissues. The company's pipeline consists of pre-CISION peptide drug conjugates (PDC) or Affimer drug conjugates (AffDC) that leverage the tumor-specific release mechanism, providing benefits over traditional antibody drug conjugates. The firm has one reportable segment, Therapeutics, which is engaged in the development of novel cancer therapies harnessing its proprietary technology. Geographically, it derives revenue from South Korea.
Name Current Vs Industry Vs History
Cash-To-Debt
1.13
Equity-to-Asset
0.08
Debt-to-Equity
6.03
Debt-to-EBITDA
-0.54
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-4.19
Distress
Grey
Safe
Beneish M-Score
4.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
22.11
9-Day RSI
37.3
14-Day RSI
45.05
3-1 Month Momentum %
12
6-1 Month Momentum %
25.75
12-1 Month Momentum %
155.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.89
Quick Ratio
0.89
Cash Ratio
0.64
Days Sales Outstanding
9666.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-18.5
Shareholder Yield %
-5.54
Name Current Vs Industry Vs History
Operating Margin %
-26053.1
Net Margin %
-34169.91
EBITDA Margin %
-24592.04
FCF Margin %
-23795.39
OCF Margin %
-23748.68
ROE %
-973.33
ROA %
-108.33
ROIC %
-93.58
3-Year ROIIC %
5.1
ROC (Joel Greenblatt) %
-478.17
ROCE %
-560.08
Moat Score
4
Tariff Resilience Score
5

Avacta Group PLC Filings

Filing Date Document Date Form
No Filing Data

Avacta Group PLC Stock Events

Financials Calendars
Event Date Price ($)
Second quarter earnings conference call for 2026 2026-09-30 13:00 In 98 days
Second quarter earnings results for 2026 2026-09-30 In 97 days
General meeting for 2025 2026-06-22 08:00 1.00 (+0.00%)
Annual report for 2025 2026-05-29 1.00 (+0.00%)
Fourth quarter earnings conference call for 2025 2026-05-19 13:00 1.23 (+0.00%)
Fourth quarter earnings results for 2025 2026-05-19 1.23 (+0.00%)
46th Annual TD Cowen Health Care Conference 2026-03-03 09:10 0.93 (+0.00%)
Second quarter earnings conference call for 2025 2025-09-30 13:00 0.75 (+0.00%)
Second quarter earnings results for 2025 2025-09-30 0.75 (+0.00%)
General meeting for 2024 2025-07-02 09:00 0.40 (+0.00%)
Show
Entries

Guru Commentaries on OTCPK:AVCTF

No articles.

Articles on Avacta Group PLC

No articles.

Headlines

See More
  • 1
No news.
  • 1